The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating cell-free tumor DNA (cfDNA) testing in small cell lung cancer.
 
Daniel Morgensztern
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Heat Biologics
Speakers' Bureau - Boehringer Ingelheim; Genentech
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Siddhartha Hk Devarakonda
No Relationships to Disclose
 
Ashiq Masood
Research Funding - Mirati Therapeutics (Inst)
 
Saiama Naheed Waqar
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst); Synermore biologics (Inst); Vertex (Inst); Xcovery (Inst)
 
Alicia C Carmack
No Relationships to Disclose
 
Kimberly C. Banks
Employment - Ambry Genetics; Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Richard Burnham Lanman
Employment - Guardant Health
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Veracyte
Research Funding - Guardant Health; Veracyte
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck